Company Info
Phone(914) 522-3885
Year Established
2016
Contacts
Anna Kazanchyan, M.D.Co-Founder & CO
Company Description
Saghmos Therapeutics is a privately held biopharmaceuticals company with a Phase 3-ready cardiorenal metabolic modulator ST-62516 (trimetazidine).